Transcriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancer

Journal of Oncology

Volumn , Issue , 2012, Pages

  Erho, Nicholas ^a   Buerki, Christine ^a   Triche, Timothy J ^a   Davicioni, Elai ^a   Vergara, Ismael A ^a  

^a GenomeDx Biosciences Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TRANSCRIPTOME;

ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PSEUDOGENE; RISK ASSESSMENT;

EID: 84866252932     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/541353     Document Type: Article

References (37)

1. Rajan P., Elliott D. J., Robson C. N., Leung H. Y., Alternative splicing and biological heterogeneity in prostate cancer. Nature Reviews Urology 2009 6 8 454 460 2-s2.0-76649088636 10.1038/nrurol.2009.125
2. Pajares M. J., Ezponda T., Catena R., Calvo A., Pio R., Montuenga L. M., Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncology 2007 8 4 349 357 2-s2.0-33947541694 10.1016/S1470-2045(07)70104- 3 (Pubitemid 46464532)
3. Boise L. H., Gonzalez-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G., Thompson C. B., bcl-x, A bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993 74 4 597 608 2-s2.0-0027282044 10.1016/0092-8674(93)90508-N (Pubitemid 23259741)
4. Chan S. C., Li Y., Dehm S. M., Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal. Journal of Biological Chemistry 2012 287 23 19736 19749 2-s2.0-84861728843 10.1074/jbc.M112.352930
5. Hu R., Isaacs W. B., Luo J., A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities. Prostate 2011 71 1656 1667 2-s2.0-79953255574 10.1002/pros.21382
6. Li Y., Hwang T. H., Oseth L. A., Hauge A., Vessella R. L., Schmechel S. C., Hirsch B., Beckman K. B., Silverstein K. A., Dehm S. M., AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression. Oncogene. In press 2-s2.0-84856002062 10.1038/onc.2011.637
7. Chudova D., Wilde J. I., Wang E. T., Wang H., Rabbee N., Egidio C. M., Reynolds J., Tom E., Pagan M., Rigl C. T., Friedman L., Wang C. C., Lanman R. B., Zeiger M., Kebebew E., Rosai J., Fellegara G., LiVolsi V. A., Kennedy G. C., Molecular classification of thyroid nodules using high-dimensionality genomic data. Journal of Clinical Endocrinology and Metabolism 2010 95 12 5296 5304 2-s2.0-78650068698 10.1210/jc.2010-1087
8. Hall J. S., Leong H. S., Armenoult L. S. C., Newton G. E., Valentine H. R., Irlam J. J., Möller-Levet C., Sikand K. A., Pepper S. D., Miller C. J., West C. M. L., Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. British Journal of Cancer 2011 104 6 971 981 2-s2.0-79952661148 10.1038/bjc.2011.66
9. Taylor B. S., Schultz N., Hieronymus H., Gopalan A., Xiao Y., Carver B. S., Arora V. K., Kaushik P., Cerami E., Reva B., Antipin Y., Mitsiades N., Landers T., Dolgalev I., Major J. E., Wilson M., Socci N. D., Lash A. E., Heguy A., Eastham J. A., Scher H. I., Reuter V. E., Scardino P. T., Sander C., Sawyers C. L., Gerald W. L., Integrative genomic profiling of human prostate cancer. Cancer Cell 2010 18 1 11 22 2-s2.0-77954255681 10.1016/j.ccr.2010.05.026
10. Vergara I. A., Erho N., Triche T. J., Ghadessi M., Crisan A., Sierocinski T., Black P. C., Buerki C., Davicioni E., Genomic Dark Matter in Prostate cancer: exploring the clinical utility of ncRNA as biomarkers. Frontiers in genetics 2012 3 23
11. McCall M. N., Bolstad B. M., Irizarry R. A., Frozen robust multiarray analysis (fRMA). Biostatistics 2010 11 2 242 253 2-s2.0-77749291770 10.1093/biostatistics/kxp059
12. McCall M. N., Irizarry R. A., Thawing frozen robust multi-array analysis (fRMA). BMC Bioinformatics 2011 12, article 369 2-s2.0-80052857450 10.1186/1471-2105-12-369
13. Yates T., xmapcore: core access to the xmap database. 2010
14. Nakagawa T., Kollmeyer T. M., Morlan B. W., Anderson S. K., Bergstralh E. J., Davis B. J., Asmann Y. W., Klee G. G., Ballman K. V., Jenkins R. B., A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS ONE 2008 3 5 2-s2.0-48449093937 10.1371/journal.pone.0002318 e2318
15. Jiang M., Ma Y., Chen C., Xuping F., Shu Y., Xia L., Guohua Y., Yumin M., Yi X., Yao L., Androgen-responsive gene database: integrated knowledge on androgen-responsive genes. Molecular Endocrinology 2009 23 11 1927 1933 2-s2.0-70350445957 10.1210/me.2009-0103
16. Cho S. Y., Choi K., Jeon J. H., Kim C. W., Shin D. M., Lee J. B., Lee S. E., Kim C. S., Park J. S., Jeong E. M., Jang G. Y., Song K. Y., Kim I. G., Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer. Experimental and Molecular Medicine 2010 42 4 310 318 2-s2.0-77951965935 10.3858/emm.2010.42.4.031
17. Quintero I. B., Araujo C. L., Pulkka A. E., Wirkkala R. S., Herrala A. M., Eskelinen E. L., Jokitalo E., Hellström P. A., Tuominen H. J., Hirvikoski P. P., Vihko P. T., Prostatic acid phosphatase is not a prostate specific target. Cancer Research 2007 67 14 6549 6554 2-s2.0-34547095781 10.1158/0008-5472.CAN-07-1651 (Pubitemid 47105498)
18. Korkmaz K. S., Elbi C., Korkmaz C. G., Loda M., Hager G. L., Saatcioglu F., Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. Journal of Biological Chemistry 2002 277 39 36689 36696 2-s2.0-0037184098 10.1074/jbc.M202414200
19. Wang L., Jin Y., Arnoldussen Y. J., Jonson I., Qu S., Mælandsmo G. M., Kristian A., Risberg B., Wæhre H., Danielsen H. E., Saatcioglu F., STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer. Cancer Research 2010 70 14 5818 5828 2-s2.0-77955048177 10.1158/0008-5472.CAN- 09-4697
20. Lin B., White J. T., Ferguson C., Bumgarner R., Friedman C., Trask B., Ellis W., Lange P., Hood L., Nelson P. S., PART-I: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12. Cancer Research 2000 60 4 858 863 2-s2.0-0034651241 (Pubitemid 30129515)
21. Ribarska T., Bastian K.-M., Koch A., Schulz W. A., Specific changes in the expression of imprinted genes in prostate cancerimplications for cancer progression and epigenetic regulation. Asian Journal of Andrology 2012 14 3 436 450 2-s2.0-84860856852 10.1038/aja.2011.160
22. Meyer K. B., Maia A. T., O'Reilly M., Ghoussaini M., Prathalingam R., Porter-Gill P., Ambs S., Prokunina-Olsson L., Carroll J., Ponder B. A. J., A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genetics 2011 7 7 2-s2.0-79960956864 10.1371/journal.pgen.1002165 e1002165
23. Skaletsky H., Kuroda-Kawaguchl T., Minx P. J., Cordum H. S., Hlllier L., Brown L. G., Repplng S., Pyntikova T., All J., Blerl T., Chinwalla A., Delehaunty A., Du H., Fewell G., Fulton L., Fulton R., Graves T., Hou S. F., Latrielle P., Leonard S., Mardis E., Maupin R., McPherson J., Miner T., Nash W., Nguyen C., Ozersky P., Pepin K., Rock S., Rohlfing T., Scott K., Schultz B., Strong C., Tin-Wollam A., Yang S. P., Waterston R. H., Wllson R. K., Rozen S., Page D. C., The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003 423 6942 825 837 2-s2.0-0037967242 10.1038/nature01722 (Pubitemid 36781267)
24. Berretta R., Moscato P., Cancer biomarker discovery: the entropic hallmark. PLoS ONE 2010 5 8 2-s2.0-77957913975 10.1371/journal.pone.0012262 e12262
25. Nam R. K., Zhang W. W., Loblaw D. A., Klotz L. H., Trachtenberg J., Jewett M. A. S., Stanimirovic A., Davies T. O., Toi A., Venkateswaran V., Sugar L., Siminovitch K. A., Narod S. A., A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer and Prostatic Diseases 2008 11 3 241 246 2-s2.0-50649087219 10.1038/sj.pcan.4501010
26. Robbins C. M., Tembe W. A., Baker A., Sinari S., Moses T. Y., Beckstrom-Sternberg S., Beckstrom-Sternberg J., Barrett M., Long J., Chinnaiyan A., Lowey J., Suh E., Pearson J. V., Craig D. W., Agus D. B., Pienta K. J., Carpten J. D., Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Research 2011 21 1 47 55 2-s2.0-78651521293 10.1101/gr.107961.110
27. Dasari V. K., Goharderakhshan R. Z., Perinchery G., Li L. C., Tanaka Y., Alonzo J., Dahiya R., Expression analysis of Y chromosome genes in human prostate cancer. Journal of Urology 2001 165 4 1335 1341 2-s2.0-0035090939 (Pubitemid 32210286)
28. Naimi B., Latil A., Fournier G., Mangin P., Cussenot O., Berthon P., Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. Prostate 2002 52 3 245 252 2-s2.0-0036680093 10.1002/pros.10104 (Pubitemid 34791225)
29. Kapranov P., St Laurent G., Raz T., Ozsolak F., Reynolds C. P., Sorensen P. H. B., Reaman G., Milos P., Arceci R. J., Thompson J. F., Triche T. J., The majority of total nuclear-encoded non-ribosomal RNA in a human cell is dark matter un-annotated RNA. BMC Biology 2010 8, article 149 2-s2.0-78650292831 10.1186/1741-7007-8-149
30. Wang B., Hasan M. K., Alvarado E., Yuan H., Wu H., Chen W. Y., NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 2011 30 8 907 921 2-s2.0-79952007931 10.1038/onc.2010.468
31. Bu H., Bormann S., Schäfer G., Horninger W., Massoner P., Neeb A., Lakshmanan V. K., Maddalo D., Nestl A., Sültmann H., Cato A. C. B., Klocker H., The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 2011 71 6 575 587 2-s2.0-79952412870 10.1002/pros.21273
32. Thorsen K., Sorensen K. D., Brems-Eskildsen A., Modin C., Gaustadnes M., Hein A. M. K., Kruhoffert M., Laurberg S., Borre M., Wang K., Brunak S., Krainer A. R., Torring N., Dyrskjott L., Andersen C. L., Orntoft T. F., Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Molecular and Cellular Proteomics 2008 7 7 1214 1224 2-s2.0-47849097478 10.1074/mcp.M700590-MCP200 (Pubitemid 352038268)
33. Yu Y. P., Landsittel D., Jing L., Nelson J., Ren B., Liu L., McDonald C., Thomas R., Dhir R., Finkelstein S., Michalopoulos G., Becich M., Luo J. H., Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. Journal of Clinical Oncology 2004 22 14 2790 2799 2-s2.0-4344561557 10.1200/JCO.2004.05.158 (Pubitemid 41079896)
34. Zhang H., Dong Y., Zhao H., Brooks J. D., Hawthorn L., Nowak N., Marshall J. R., Gao A. C., Ip C., Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. Cancer Genomics and Proteomics 2005 2 2 97 113 2-s2.0-20344379480 (Pubitemid 40791355)
35. Kanamori T., Takakura K., Mandai M., Kariya M., Fukuhara K., Kusakari T., Momma C., Shime H., Yagi H., Konishi M., Suzuki A., Matsumura N., Nanbu K., Fujita J., Fujii S., PEP-19 overexpression in human uterine leiomyoma. Molecular Human Reproduction 2003 9 11 709 717 2-s2.0-0345327714 10.1093/molehr/gag088 (Pubitemid 37483958)
36. Kattan M. W., Wheeler T. M., Scardino P. T., Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. Journal of Clinical Oncology 1999 17 5 1499 1507 2-s2.0-0032950295 (Pubitemid 29220858)
37. Prensner J. R., Iyer M. K., Balbin O. A., Dhanasekaran S. M., Cao Q., Brenner J. C., Laxman B., Asangani I. A., Grasso C. S., Kominsky H. D., Cao X., Jing X., Wang X., Siddiqui J., Wei J. T., Robinson D., Iyer H. K., Palanisamy N., Maher C. A., Chinnaiyan A. M., Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology 2011 29 8 742 749 2-s2.0-79961202865 10.1038/nbt.1914